You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,626,531


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,626,531
Title: Prostaglandins and antigestagens for induction of labor and for abortion
Abstract:A pharmaceutical composition containing a prostaglandin and an antigestagen is suitable for induction of labor and for abortion.
Inventor(s): Elger; Walter (Berlin, DE), Beier; Sybille (Berlin, DE)
Assignee: Schering Aktiengesellschaft (Berlin and Bergkamen, DE)
Application Number:06/660,358
Patent Claim Types:
see list of patent claims
Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,626,531

Introduction

United States Patent 4,626,531, assigned to Bayer Pharma AG, is a significant patent that deals with prostaglandins and antigestagens, particularly for the induction of labor and abortion. To delve into the details of this patent, we need to analyze its scope, claims, and the broader patent landscape.

Patent Overview

Title and Assignees: The patent titled "Prostaglandins and Antigestagens for Induction of Labor and for Abortion" was assigned to Bayer Pharma AG, with a priority date of October 12, 1983[5].

Scope of the Patent

The scope of a patent is defined by its claims, which outline the specific inventions or innovations covered by the patent.

Independent and Dependent Claims

The patent includes both independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims. For US Patent 4,626,531, the independent claims likely focus on the specific compounds, their uses, and methods of administration for inducing labor and abortion.

Claim Language and Metrics

Research on patent scope often uses metrics such as independent claim length and independent claim count to measure the breadth of a patent. Narrower claims, as indicated by shorter lengths and fewer counts, are generally associated with a higher probability of grant and a shorter examination process[3].

Claims Analysis

Claim Structure

  • Independent Claims: These claims define the core invention, such as the specific prostaglandins and antigestagens, their formulations, and their use in medical procedures.
  • Dependent Claims: These claims build upon the independent claims, providing additional details or limitations, such as specific dosages, administration methods, or combinations with other compounds.

Claim Examples

While the exact claims of US Patent 4,626,531 are not detailed here, they would typically include:

  • Claims for the chemical structure of the prostaglandins and antigestagens.
  • Claims for the methods of synthesizing these compounds.
  • Claims for the use of these compounds in inducing labor or abortion.
  • Claims for specific formulations, such as tablets, gels, or injectables.

Patent Landscape

Prior Art and Citations

To understand the patent landscape, it is crucial to look at prior art and citations. The Common Citation Document (CCD) application, for instance, consolidates prior art cited by multiple patent offices, helping to visualize the search results for the same invention across different offices[4].

Related Patents and Applications

The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including related applications filed at participating IP offices. This can help identify other patents and applications that are related to US Patent 4,626,531[4].

Exclusivity and Patent Certifications

Patent Exclusivity

For a patent to be eligible for exclusivity, new investigations essential to its approval must have been conducted or sponsored by the applicant. This is particularly relevant in the context of pharmaceuticals, where clinical trials and safety studies are critical[1].

Patent Certifications

The application for US Patent 4,626,531 would have included patent certifications, such as Paragraph I, II, or III certifications, which address the patent status of the listed drug. These certifications are crucial for determining the patent's validity and expiration dates[1].

Litigation and Enforcement

Small Claims Patent Court

In the context of patent enforcement, the concept of a small claims patent court has been discussed as a potential solution to reduce the costs and complexities associated with patent litigation. This could impact how future disputes related to patents like US 4,626,531 are handled[2].

International Patent Landscape

Global Patent Search

To ensure that the invention is novel and non-obvious, a thorough global patent search is necessary. Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) are essential tools for this purpose[4].

Conclusion

Understanding the scope and claims of US Patent 4,626,531 involves a detailed analysis of its claim structure, the broader patent landscape, and the regulatory environment. Here are the key takeaways:

  • Claim Structure: The patent includes independent and dependent claims that define the invention and its limitations.
  • Patent Landscape: The patent is part of a larger landscape that includes prior art, related patents, and global patent families.
  • Exclusivity and Certifications: The patent's eligibility for exclusivity and the certifications provided are critical for its validity and enforcement.
  • Litigation and Enforcement: The potential for small claims patent courts and international patent search tools are important considerations for future disputes and validations.

Key Takeaways

  • Claim Analysis: Independent and dependent claims define the invention and its scope.
  • Patent Landscape: Prior art, citations, and related patents are crucial for understanding the patent's position.
  • Exclusivity and Certifications: New investigations and patent certifications are essential for exclusivity and validity.
  • Global Considerations: International patent searches and databases are vital for ensuring novelty and non-obviousness.
  • Litigation: Small claims patent courts could simplify future litigation processes.

FAQs

Q: What is the primary focus of US Patent 4,626,531? A: The primary focus is on prostaglandins and antigestagens for the induction of labor and abortion.

Q: How are patent claims structured in this patent? A: The patent includes independent claims that define the core invention and dependent claims that further limit the independent claims.

Q: What is the significance of the Global Dossier service in patent searching? A: The Global Dossier service allows users to see the patent family for a specific application, including related applications filed at participating IP offices.

Q: How does the concept of a small claims patent court impact patent enforcement? A: It could reduce the costs and complexities associated with patent litigation, making it easier for smaller entities to enforce their patents.

Q: Why is international patent searching important for patents like US 4,626,531? A: It ensures that the invention is novel and non-obvious by checking against prior art and existing patents globally.

Sources

  1. FDA NDA Application: "202107Orig1s000 - accessdata.fda.gov"
  2. ACUS Study on Small Claims Patent Court: "U.S. Patent Small Claims Court - acus.gov"
  3. SSRN Paper on Patent Scope: "Patent Claims and Patent Scope - SSRN"
  4. USPTO Patent Search Resources: "Search for patents - USPTO"
  5. Unified Patents Portal: "US-4870067-A - Unified Patents Portal"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,626,531

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 4,626,531

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3337450Oct 12, 1983

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.